Hubbard Robert Glenn has demonstrated a clear bias toward buying securities across multiple companies, as evidenced by SEC Form 4 filings. Over the course of 30 transactions spanning nine companies, Hubbard’s total buy value amounted to $441,979.57, significantly outweighing the total sell value of $7,086.45. Notably, the majority of these transactions involved acquiring shares in companies such as MET (MetLife, Inc.), BDJ, BTZ, CII, and BLW, with MET accounting for the largest individual transactions. For example, on January 2, 2026, Hubbard acquired MET shares valued at $88,753.60, following a similar purchase of $75,047.88 on October 1, 2025. These sizable acquisitions underscore a consistent pattern of investment in MET, among other holdings.
Recent filings, however, indicate a pause in Hubbard’s trading activity, with no buys or sells recorded in the immediate past. The last notable transactions occurred in early 2026, including a $54,432.60 acquisition of MET shares on March 10, 2026, and smaller transactions involving tickers like MUA, BKN, and BTA, primarily categorized as transfers or exchanges (denoted by code “J”) with minimal or no monetary value. This lull in activity contrasts with the earlier period of concentrated buying, particularly in MET and other securities. Hubbard’s trading history reflects a strategy focused on accumulating shares across a diversified portfolio, with a marked preference for long-term investment over short-term selling. The absence of recent activity suggests a period of consolidation or reevaluation of holdings.
AI-assisted summary